While we're at it, here are a few more acquisitions that should happen right now.

Mylan's deal to buy Perrigo is taking another potential target off the block.

Teva, Actavis and other generics giants may start preying on each other.

With the recent deal for DAVA, Endo is now one of the best health care stocks to own.

These heavily shorted stocks could get squeezed on any positive catalyst.

The markets' slide particularly hurts retirees, who may have to sell some of their stocks and bonds to finance spending.

Ford has recently cast a shadow over the auto industry.

Short sellers reversed course and sold $19 billion of shorts in September.

The parent company of Google and Youtube is preparing for a sharp deterioration in the health of the economy.